Mohamed Mahadi

Radiology ST3 in East Yorkshire. Interested in all aspects of neuroradiology, especially neurovascular. Always looking for new ways to learn and improve.

[Hunain Shiwani @HunainShiwani]

Glad to see our paper published in the European Heart Journal: Cardiovascular Imaging @ESC_Journals!

In 5,675 Cardiac MRI studies, asymmetrical septal hypertrophy (ASH) was present in 61% of hypertrophic cardiomyopathy (HCM) patients, but also 37% of ATTR amyloidosis, 26% of aortic stenosis and 23% of AL amyloidosis.

After accounting for age, sex & body size, however, excess asymmetry remained uniquely associated with HCM (ΔSLR +0.27).

https://t.co/2xiIv1ncWk

[NEJM @NEJM]

Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: https://t.co/FvyLPQz4CV

Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population https://t.co/hnLi0DvzuF

[AHA Science @AHAScience]

🧵/Late-breaking science results from #ISC26 will be posted to this thread at the time of presentation.

(bookmark this post)

CHOICE2
FASTEST
CREST-2
OCEANIC-STROKE
EMBOLISE
LFAIS
LB035

[Braydon Dymm, MD @BraydonDymm]

2025 was a landmark year for stroke neurology.

From the MeVO trials to news of AI-driven systems of care and Factor XIa inhibitors on the horizon, the landscape of vascular neurology has shifted.

Here's a month-by-month recap of the year! 🧵

[Sameer Raniga @samrad77]

In transfusion-dependent thalassemia, the pituitary gland may appear small and hypointense (dark) on T2W MRI, which is characteristic of iron deposition (hemosiderosis).

An early clue to future hypogonadism and growth failure.

—Every signal tells a story- from my reporting list

[Adel Malek MD PhD @adelmalek]

https://t.co/gtfIlBZ6KF

[Neurology Journal @GreenJournal]

This study provides Class III evidence that in adult patients with anterior circulation large vessel occlusion & low NIHSS score (≤5) presenting in late time window (6–24 hrs), endovascular therapy does not improve clinical outcome vs medical management: https://t.co/shS4ulrOIr

[Mo Daf @MoDafaalla]

Our article about the PRECISE-DAPT CANCER score was selected as one of the top 10 articles in cardio-oncology published in 2024.
A huge achievement that was not meant to happen without the support of @mmamas1973 and @Costa_F_8 .

https://t.co/hKRM0gaaGk

https://t.co/ystR17uq8k

[Johanna Seiden, MD MPH @JohannaSeidenMD]

3 Medium Vessel Occlusion Trials presented today during the plenary session- DISTAL (photo 1), ESCAPE-MeVO (Photo 2), and DISCOUNT (Photo 3) unequivocally showed no benefit of EVT over best medical management. #ISC25 #aha @StrokeAHA_ASA

[BSNR @theBSNR]

We are pleased to announce our new neuroimaging course for general radiologists and senior trainees!
Excellent CPD with online scrollable cases and expert faculty.
📆5/3/25
💷Early bird 5/2/25- only £125, with further discounts for members & trainees

https://t.co/7PPCAKGWgQ

[BSNR @theBSNR]

We are very pleased to announce our first online Stroke Imaging Day!

A fantastic lineup of speakers and interactive cases, of interest to anyone involved in acute stroke care.

⏲️ 31st January 2025
💷£50-150
✅Register here: https://t.co/40sWPi6IqB

#stroke #neurorad

[UofT Medical Imaging @UofTMedIm]

Congrats to Dr. @B_Shyamanur, Abdominal Imaging Fellow, who received a Certificate of Merit at this year's @RSNA Annual Meeting for her presentation titled, "The Atypical & Equivocal Appendix," on which she collaborated with Assoc. Professor Dr. @SatheeshToronto Krishna Jeyaraj.

[JNIS @JNIS_BMJ]

🤓 Do you know your vertebrobasilar perforators? Check out this review with fantastic images from @eytanraz @neuroangio1 @ENossek @MatthewPottsMD @SharashidzeVera @ChungCharlotte @rdeleacymd Link: https://t.co/lq7dTUpXqD

[Ashar Asif @ashetabulum]

Grateful to have worked on this under @saira_sayeed and @ragsxray supervision. In short, we have a long way to go for our patients. Some interesting work coming up in the pipeline- keep your eyes peeled!

[Shahid Seedat @shahid_seedat]

@ashetabulum, our clinical research fellow discusses chronic mesenteric ischaemia, which won best educational poster - Hull continuing to fly the flag for vascular IR, and investing in our future!
@saira_sayeed @ragsxray @BSIR_News @NHSHHP @HullHospitals

[Tim Tonkin @BMAtim]

Members at #ARM2024 have voted to endorse calls to rename "Junior doctors" to "Resident doctors".

[BSER @bseradiology]

Join us for our 2nd webinar on Friday 19th April at 6:30pm. We’ll be joined by Dr Adam Davies who will be delivering a talk on ‘Acute Spine’! Register now on our website! :)

[NeuroNews @NN_publishing]

Federico Corti delivers late-breaking research demonstrating that delayed therapy with a novel human monoclonal antibody (anti-Sdc2 mAb) was able to prevent formation of vasogenic oedema and promote neuroprotection in non-human primates with ischaemic #Stroke
#ISC24 #ISC2024

[Thanh Lam "Lance" Tran @Lance_Tran_]

Dr Corti from Yale introduces Anti-Sdc2 mAb as a promising therapy tested in non-human primates. #ISC24

1. Edema reduction majority of revascularization benefit.
2. VEGF-A is a driver of edema, so inhibition using Sdc2 tested in animal models
3. Sdc2 mAb reduced infarct volume!

[Dr Harun Yıldız @drharunyildiz]

Basal Venous Circle (Trolard Circle)

#radiologicalillustration ✍️
pixel by pixel handmade!